S’pore Firm Lucence Raises US$20M To Advance Its Non-Invasive Cancer Detection Tech

Singapore-based genomic medicine firm Lucence announced today the close of a US$20 million Series A funding round. The round was led by IHH Healthcare, one of the world’s largest integrated private healthcare groups. Others that participated in the round include SGInnovate and existing investors like Temasek Holdings subsidiary Heliconia Capital, Lim Kaling, and Koh Boon…(Continue Reading)